Results 91 to 100 of about 699,373 (191)

Intravitreal Bevacizumab Injection Therapy in a Case with Choroidal Neovascular Membrane Secondary to Toxoplasmosis Retinochoroiditis

, 2014
A 57-year-old male patient presenting with visual loss in the left eye was diagnosed as choroidal neovascular membrane secondary to inactive toxoplasmosis retinochoroiditis scar. He underwent intravitreal bevacizumab injection as primary therapy.
Sirel Gür Güngör, Gürsel Yılmaz, Evin Şingar, İmren Akkoyun   +3 more
core   +1 more source

Suppression of Neovascularization by Topical and Subconjunctival Bevacizumab After High-Risk Corneal Transplantation

Ophthalmology Science
Purpose: To assess the effectiveness of topical and subconjunctival bevacizumab in suppressing vascularization in graft and host bed after high-risk corneal transplantation.
Thomas H. Dohlman, MD, Rohan Bir Singh, MD, Francisco Amparo, MD, Tatiana Carreno-Galeano, MD, Mohammad Dastjerdi, MD, Giulia Coco, MD, Antonio Di Zazzo, MD, Hasanain Shikari, MD, Ujwala Saboo, MD, Kimberly Sippel, MD, Jessica Ciralsky, MD, Sonia H. Yoo, MD, Matheus Sticca, MD, Tais H. Wakamatsu, MD, Somasheila Murthy, MD, Pedram Hamrah, MD, Ula Jurkunas, MD, Joseph B. Ciolino, MD, Hajirah Saeed, MD, MPH, Jose A.P. Gomes, MD, Victor L. Perez, MD, Jia Yin, MD, PhD, MPH, Reza Dana, MD, MPH   +22 more
doaj   +1 more source

ISEV2025 Abstract Book

Journal of Extracellular Vesicles, Volume 14, Issue S1, October 2025.
wiley   +1 more source

Comparison of Corneal Endothelial Changes After a Single-Dose Injection of Bevacizumab or Ranibizumab

, 2013
Purpose: To compare the corneal endothelial changes after injection of a single-dose intravitreal bevacizumab or intravitreal ranibizumab. Material and Method: In this retrospective study, we evaluated 27 eyes of 27 patients with either diabetic ...
Tansu Gönen, Mustafa Yaşar, Fatih Horozoğlu   +2 more
core   +1 more source

Publication Only

HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Efficacy of Sub-Conjunctival Injection of Mitomycin C Versus Bevacizumab in Pterygium Treatment: Pakistani Population

Pakistan Journal of Medicine and Dentistry
Background: Pterygium is a progressive fibrovascular tissue that affects the conjunctiva and cornea. The aim of the study was to compare the efficacy of Sub-conjunctival injection of Mitomycin C versus Bevacizumab in pterygium treatment focusing on ...
Amber khalid, Sharjeel Sultan, Aveen Fatima, Ayesha Khalid, Maryam Shifa   +4 more
doaj   +1 more source

Comparison of the Effects of Subconjunctival Injections of Bevacizumab and Interferon Alpha-2a on Corneal Angiogenesis in a Rat Model

, 2018
Background and objective: Corneal neovascularization (CNV) is a vision-threatening condition arising from various corneal diseases. The aim of this study is to compare the effectiveness of bevacizumab and interferon alpha-2a (IFNα-2a) treatment on ...
Sinan Bilgin
core   +1 more source

Delayed recurrent hyphema following trabeculectomy: A case series of swan syndrome managed with anti-VEGF therapy

Indian Journal of Ophthalmology. Case Reports
Swan syndrome refers to delayed recurrent intraocular bleeding caused by vascular ingrowth at the site of a prior surgical wound. Although classically described after cataract surgery, it has rarely been reported following trabeculectomy. We report three
Priyanka Sudhakar, Gowri J Murthy, Praveen R Murthy   +2 more
doaj   +1 more source

Progressive anterior segment involvement of an infant with corneoscleral juvenile xanthogranuloma refractory to topical steroids

American Journal of Ophthalmology Case Reports
Purpose: To report a case of corneoscleral juvenile xanthogranuloma (JXG) with progressive anterior segment involvement refractory to topical steroids. Observations: A 4-month-old male was referred for a new-onset subconjunctival lesion in the right eye.
Sanjana Suraneni, Charissa H. Tan, Lindsay M. Foley, Sander R. Dubovy, Basil K. Williams, Audina M. Berrocal, Ta Chen Chang, Angela Y. Zhu   +7 more
doaj   +1 more source

Triple subconjunctival bevacizumab injection for early corneal recurrent pterygium: one-year follow-up. [PDF]

J Ocul Pharmacol Ther, 2015
Nava-Castañeda A, Ulloa-Orozco I, Garnica-Hayashi L, Hernandez-Orgaz J, Jimenez-Martinez MC, Garfias Y.   +5 more
europepmc   +1 more source